121 related articles for article (PubMed ID: 38069915)
1. Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study.
Welsh P; Kimenai DM; Shah ASV; Gadd DA; Marioni RE; Woodward M; Sudlow CLM; Campbell A; Cleland JGF; Pellicori P; Hayward C; Mills NL; Sattar N
Clin Chem; 2024 Feb; 70(2):403-413. PubMed ID: 38069915
[TBL] [Abstract][Full Text] [Related]
2. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
[TBL] [Abstract][Full Text] [Related]
3. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
4. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
Apple FS; Murakami MM; Pearce LA; Herzog CA
Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
[TBL] [Abstract][Full Text] [Related]
5. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
Costacou T; Saenger AK; Orchard TJ
Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
[TBL] [Abstract][Full Text] [Related]
6. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
8. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study.
Daniels LB; Clopton P; Laughlin GA; Maisel AS; Barrett-Connor E
Circulation; 2011 May; 123(19):2101-10. PubMed ID: 21536998
[TBL] [Abstract][Full Text] [Related]
9. Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.
Gürgöze MT; Akkerhuis KM; Oemrawsingh RM; Umans VAWM; Kietselaer B; Schotborgh CE; Ronner E; Lenderink T; Aksoy I; van der Harst P; Asselbergs FW; Maas AC; Oude Ophuis AJ; Krenning B; de Winter RJ; The SHK; Wardeh AJ; Hermans WRM; Cramer GE; van Gorp I; de Rijke YB; van Schaik RHN; Boersma E
Eur Heart J Acute Cardiovasc Care; 2023 Jul; 12(7):451-461. PubMed ID: 37096818
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
[TBL] [Abstract][Full Text] [Related]
11. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.
Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M
Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
13. Multimarker Analysis of Serially Measured GDF-15, NT-proBNP, ST2, GAL-3, cTnI, Creatinine, and Prognosis in Acute Heart Failure.
Gürgöze MT; van Vark LC; Baart SJ; Kardys I; Akkerhuis KM; Manintveld OC; Postmus D; Hillege HL; Lesman-Leegte I; Asselbergs FW; Brunner-la-Rocca HP; van den Bos EJ; Orsel JG; de Ridder SPJ; Pinto YM; Boersma E
Circ Heart Fail; 2023 Jan; 16(1):e009526. PubMed ID: 36408685
[TBL] [Abstract][Full Text] [Related]
14. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial.
Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA
Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908
[TBL] [Abstract][Full Text] [Related]
15. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
[TBL] [Abstract][Full Text] [Related]
16. Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.
Eggers KM; Lindahl B; Venge P; Lind L
Int J Cardiol; 2018 Apr; 257():300-305. PubMed ID: 29506712
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
[TBL] [Abstract][Full Text] [Related]
18. Biomarker-based prediction of fatal and non-fatal cardiovascular outcomes in individuals with diabetes mellitus.
Haller PM; Goßling A; Magnussen C; Brenner H; Schöttker B; Iacoviello L; Costanzo S; Kee F; Koenig W; Linneberg A; Sujana C; Thorand B; Salomaa V; Niiranen TJ; Söderberg S; Völzke H; Dörr M; Sans S; Padró T; Felix SB; Nauck M; Petersmann A; Palmieri L; Donfrancesco C; De Ponti R; Veronesi G; Ferrario MM; Kuulasmaa K; Zeller T; Ojeda FM; Blankenberg S; Westermann D;
Eur J Prev Cardiol; 2023 Sep; 30(12):1218-1226. PubMed ID: 37079290
[TBL] [Abstract][Full Text] [Related]
19. Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation.
Matusik PT; Małecka B; Lelakowski J; Undas A
Clin Res Cardiol; 2020 Apr; 109(4):426-434. PubMed ID: 31280356
[TBL] [Abstract][Full Text] [Related]
20. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]